Thymosin Alpha 9mg
Master immune modulator — antiviral, anti-inflammatory & cancer support
Full Details & Dosage GuideClinical Uses
- Chronic viral infections (EBV, CMV, hepatitis)
- Immune reconstitution after chemotherapy or illness
- Autoimmune conditions (modulation not suppression)
- Cancer adjunct immunotherapy
- Long COVID immune dysregulation
- Vaccine response enhancement
Key Benefits
- Clinically proven to restore T-cell counts and function
- Used in 70+ countries for hepatitis B, hepatitis C, and cancer immunotherapy
- Both immunostimulatory and immunoregulatory — corrects dysfunction in both directions
- Reduces chronic inflammatory cytokine burden
- Enhances NK cell and dendritic cell activity
- No serious adverse events in clinical trials
How It Works
Thymosin Alpha-1 (Tα1) is a 28-amino-acid peptide naturally secreted by thymic epithelial cells. It modulates innate and adaptive immunity by upregulating MHC class I and II expression on antigen-presenting cells, enhancing T-helper 1 responses, and increasing IL-2 production. It simultaneously suppresses overactive inflammatory pathways (TNF-α, IL-6, IL-1β) in autoimmune conditions.
Dosage Protocol
1.6 mg subcutaneous injection twice weekly. In acute viral or immune conditions: 1.6 mg daily for 4–8 weeks. Maintenance: twice weekly indefinitely. 9mg vials support extended protocols.
When to Expect Results
Weeks 1–2: improved innate immune signaling, reduced fatigue. Weeks 3–6: measurable increase in CD4/CD8 T-cell counts. Weeks 6–12: antiviral load reduction and improved inflammatory markers.
KPV 10mg
Anti-inflammatory tripeptide — IBD, skin conditions & gut healing
Full Details & Dosage GuideClinical Uses
- Inflammatory bowel disease (Crohn's, ulcerative colitis)
- Skin inflammation and wound healing
- Systemic anti-inflammatory therapy
- Gut barrier repair (leaky gut syndrome)
- Psoriasis and eczema management
Key Benefits
- Potent anti-inflammatory without immunosuppression
- Directly reduces NF-κB signaling — the master inflammation switch
- Works locally in the GI tract when taken orally
- Highly safe with no known serious side effects
- Synergizes with BPC-157 for comprehensive gut repair
How It Works
KPV is a tripeptide (Lys-Pro-Val) derived from the C-terminus of alpha-melanocyte stimulating hormone (α-MSH). It exerts anti-inflammatory effects by binding melanocortin receptors (MC1R, MC3R) on immune cells, directly inhibiting NF-κB translocation to the nucleus, blocking pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) without generalized immunosuppression.
Dosage Protocol
Systemic: 250–500 mcg subcutaneous injection once or twice daily. GI conditions: 500 mcg–1 mg orally twice daily. Topical creams for skin. Course: 4–12 weeks.
When to Expect Results
Days 3–7: reduction in inflammatory markers. Weeks 2–4: improved GI symptoms. Weeks 4–8: measurable mucosal healing. Skin improvement visible within 2–3 weeks.
KPV 250mcg
Oral KPV — gut inflammation & systemic immune support
Full Details & Dosage GuideClinical Uses
- Inflammatory bowel disease (Crohn's, ulcerative colitis)
- Skin inflammation and wound healing
- Systemic anti-inflammatory therapy
- Gut barrier repair (leaky gut syndrome)
Key Benefits
- Potent anti-inflammatory without immunosuppression
- Directly reduces NF-κB signaling
- Works locally in the GI tract when taken orally
- Highly safe with no known serious side effects
How It Works
KPV is a tripeptide (Lys-Pro-Val) derived from α-MSH. It binds melanocortin receptors on immune cells, inhibiting NF-κB nuclear translocation and blocking pro-inflammatory cytokine production without causing immunosuppression.
Dosage Protocol
250 mcg subcutaneous injection once or twice daily, or orally for GI conditions. Course: 4–12 weeks. Ideal for sensitive patients or as maintenance dose.
When to Expect Results
Days 3–7: reduced inflammation. Weeks 2–4: GI symptom improvement. Weeks 4–8: mucosal healing measurable.
KPV 500mcg
High-dose oral KPV for IBD, Crohn's & chronic inflammation
Full Details & Dosage GuideClinical Uses
- Inflammatory bowel disease
- Systemic anti-inflammatory therapy
- Post-surgical inflammation reduction
- Gut barrier repair
- Psoriasis and eczema management
Key Benefits
- Standard therapeutic KPV dose for most conditions
- Potent NF-κB inhibition
- Works orally for gut and subcutaneously for systemic effect
- Synergizes with BPC-157 for gut repair
How It Works
KPV tripeptide from α-MSH. Binds melanocortin receptors MC1R/MC3R on immune cells, blocks NF-κB-mediated inflammatory cascades. Anti-inflammatory without immunosuppression.
Dosage Protocol
500 mcg subcutaneous injection once daily, or 500 mcg orally twice daily for GI conditions. 4–12 week protocols.
When to Expect Results
Days 3–7: inflammation reduction. Weeks 2–4: GI symptom improvement. Weeks 4–8: mucosal healing. Weeks 8–12: sustained remission.
Peptide Golden GUT 500mcg + 500mcg
Dual peptide gut stack — comprehensive digestive and immune support
Full Details & Dosage GuideClinical Uses
- Comprehensive gut restoration
- Leaky gut and intestinal permeability repair
- IBD and IBS management
- Post-antibiotic gut recovery
- Chronic gut inflammation
Key Benefits
- Dual-peptide formula targeting both inflammation and structural repair
- Repairs tight junctions of the intestinal epithelium
- Reduces gut-derived systemic inflammation
- Supports microbiome homeostasis
- Improves nutrient absorption by restoring gut integrity
How It Works
GHH's Golden GUT formula combines a GI-targeted anti-inflammatory (KPV-class) and a structural repair peptide (BPC-157 class). Together they activate FAK-paxillin pathways for epithelial cell migration, reduce mucosal NF-κB activation, promote mucosal angiogenesis, and restore tight junction proteins (occludin, claudin).
Dosage Protocol
500 mcg + 500 mcg orally twice daily on an empty stomach. Dissolve in cool water. Run for 4–12 weeks. Can be combined with subcutaneous BPC-157 for severe cases.
When to Expect Results
Days 3–7: reduced bloating and GI discomfort. Weeks 2–4: improved stool consistency. Weeks 4–8: measurable reduction in gut permeability markers. Weeks 8–12: mucosal healing confirmed.
All peptides require UAE licensed physician review and mandatory blood work before dispensing. All protocols are subject to physician approval. Results vary by individual. These statements are for informational purposes only and do not constitute medical advice.